Comparable stake leader
Five Narrow Lane LP
SEC ownership of ORAGENICS INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001174940.
Disclosed value leader
Bruce A. Cassidy Sr.
Comparable rows
14/27
Latest evidence
01 Jul 2026
- Public ticker
- OGEN on NYSE
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Five Narrow Lane LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
14 of 27
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Five Narrow Lane LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
01 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001174940
- Issuer location
- Lakewood Ranch, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ORAGENICS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Five Narrow Lane LP
Disclosed value leader
Bruce A. Cassidy Sr.
Comparable rows
14/27
Latest evidence
01 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
13 rows are not safely comparable across share classes.
13D/G row: Five Narrow Lane LP
Showing 1-8 of 27 holder rows.
Quick read
Five Narrow Lane LP leads the comparable SEC ownership view at 10%.
14 of 27 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Five Narrow Lane LP's linked filing trail.
Comparable ownership
Top 5
Five Narrow Lane LP
10%
SABBY MANAGEMENT, LLC
9.9%
GEODE CAPITAL MANAGEMENT, LLC
0.57%
25 LLC
0.56%
Tower Research Capital LLC (TRC)
0.11%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 27 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Five Narrow Lane LP |
13D/G
|
10%
|
—
82,210 shares
|
$0 | 02 Jul 2025 |
| SABBY MANAGEMENT, LLC |
13D/G
|
9.9%
|
$354,882
412,654 shares
|
$0 | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.57%
|
$13,750
23,685 shares
|
— | 30 Jun 2026 |
| 25 LLC |
13F
Company
|
0.56%
|
$13,447
23,160 shares
|
— | 30 Jun 2026 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.11%
|
$2,641
4,548 shares
|
— | 30 Jun 2026 |
| St. Johns Investment Management Company, LLC |
13F
Company
|
0.05%
|
$1,117
1,924 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
0.02%
|
$408
703 shares
|
— | 30 Jun 2026 |
| HARBOUR INVESTMENTS, INC. |
13F
Company
|
0%
|
$20
34 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$198.
Buys
$0
Insiders: 0
Sells
$198
Insiders: 1
Net
-$198
Shares: -210
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 210
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 210 | $0 | $198 | -$198 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to ORAGENICS INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest Forms 3/4/5 holder
Bruce A. Cassidy Sr.
Net 12M change
-$198
Latest report
01 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bruce A. Cassidy Sr. | Director | $1,265,705 | Mixed | 19 Sep 2024 | ||
| Fred Telling | Director | $895 | -$198 | -18% | Filing P/S | 11 Dec 2025 |
| John Spencer | Chief Financial Officer | $29 | Mixed | 01 Jul 2026 | ||
| Odyssey Health, Inc. | 10%+ Owner | $0 | Mixed | 17 Jun 2025 | ||
| Janet Huffman | CEO and CFO | Mixed | 11 Dec 2025 | |||
| Kimberly M. Murphy | Director | Mixed | 19 Sep 2024 | |||
| John P. Gandolfo | Director | Mixed | 11 Dec 2025 | |||
| Robert C. Koski | Director | Mixed | 11 Dec 2025 | |||
| Natasha Giordano | Director | Mixed | 11 Dec 2025 | |||
| Michael O Sullivan | Chief Financial Officer | Mixed | 29 Jul 2022 | |||
| J. Michael Redmond | President | Mixed | 19 Sep 2024 | |||
| Charles L. Pope | Director | Mixed | 11 Dec 2025 | |||
| Alan W. Dunton | Director | Mixed | 11 Dec 2025 |
Recent insider transactions for ORAGENICS INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| John Spencer | OGEN | Employee Stock Option (right to buy) | Award | 55,900 | 55,900 | 01 Jul 2026 | Direct | |||
| Fred Telling | OGEN | Common Stock | Sale | -18.1% | $198 | $0.9446 | -210 | 948 | 12 Dec 2025 | Direct |
| Fred Telling | OGEN | Non-Employee Director Option (Right to Buy) | Award | 125,000 | 125,000 | 11 Dec 2025 | Direct | |||
| Janet Huffman | OGEN | Employee Stock Option (right to buy) | Award | 250,000 | 250,000 | 11 Dec 2025 | Direct | |||
| Natasha Giordano | OGEN | Non-Employee Director Option (Right to Buy) | Award | 163,320 | 125,000 | 11 Dec 2025 | Direct | |||
| John P. Gandolfo | OGEN | Non-Employee Director Option (Right to Buy) | Award | 125,000 | 125,000 | 11 Dec 2025 | Direct | |||
| Alan W. Dunton | OGEN | Non-Employee Director Option (Right to Buy) | Award | 125,000 | 125,000 | 11 Dec 2025 | Direct | |||
| Robert C. Koski | OGEN | Non-Employee Director Option (Right to Buy) | Award | 125,000 | 125,000 | 11 Dec 2025 | Direct | |||
| Charles L. Pope | OGEN | Non-Employee Director Option (Right to Buy) | Award | 125,000 | 125,000 | 11 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.